EXTON, Pa., March 2 /PRNewswire-FirstCall/ -- Fibrocell Science, Inc. announced today that the Company has entered into a Securities Purchase Agreement with certain accredited investors, pursuant to which the Company agreed to sell to the purchasers in the aggregate 5,076,667 shares of Company common stock at a purchase price of $0.75 per share. Each purchaser will also receive a warrant to purchase the same number of shares of common stock acquired in the offering at an exercise price of $0.98 per share. The aggregate purchase price to be paid by the purchasers at closing for the common stock and the warrants will be $3,807,500. The financing is subject to customary closing conditions. None of the shares to be issued to the investors nor the shares underlying the warrants to be issued to the investors or the placement agents will be or have been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
About Fibrocell Science, Inc.
Forward Looking Statements
CONTACT: Mike Beyer of Sam Brown Inc. for Fibrocell Science, Inc.,
+1-773-463-4211, beyer@sambrown.com
Web site: http://www.fibrocellscience.com/
